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Abstract
Atrial fibrillation (AF) is the most common cardiac arrhythmia, but our knowledge of the arrhythmogenic substrate is
incomplete. Alternans, the beat-to-beat alternation in the shape of cardiac electrical signals, typically occurs at fast heart
rates and leads to arrhythmia. However, atrial alternans have been observed at slower pacing rates in AF patients than in
controls, suggesting that increased vulnerability to arrhythmia in AF patients may be due to the proarrythmic influence of
alternans at these slower rates. As such, alternans may present a useful therapeutic target for the treatment and prevention
of AF, but the mechanism underlying alternans occurrence in AF patients at heart rates near rest is unknown. The goal of
this study was to determine how cellular changes that occur in human AF affect the appearance of alternans at heart rates
near rest. To achieve this, we developed a computational model of human atrial tissue incorporating electrophysiological
remodeling associated with chronic AF (cAF) and performed parameter sensitivity analysis of ionic model parameters to
determine which cellular changes led to alternans. Of the 20 parameters tested, only decreasing the ryanodine receptor
(RyR) inactivation rate constant (kiCa) produced action potential duration (APD) alternans seen clinically at slower pacing
rates. Using single-cell clamps of voltage, fluxes, and state variables, we determined that alternans onset was Ca2+-driven
rather than voltage-driven and occurred as a result of decreased RyR inactivation which led to increased steepness of the
sarcoplasmic reticulum (SR) Ca2+ release slope. Iterated map analysis revealed that because SR Ca2+ uptake efficiency was
much higher in control atrial cells than in cAF cells, drastic reductions in kiCa were required to produce alternans at
comparable pacing rates in control atrial cells. These findings suggest that RyR kinetics may play a critical role in altered Ca2+
homeostasis which drives proarrhythmic APD alternans in patients with AF.
Citation: Chang KC, Bayer JD, Trayanova NA (2014) Disrupted Calcium Release as a Mechanism for Atrial Alternans Associated with Human Atrial Fibrillation. PLoS
Comput Biol 10(12): e1004011. doi:10.1371/journal.pcbi.1004011
Editor: Andrew D. McCulloch, University of California San Diego, United States of America
Received May 27, 2014; Accepted October 29, 2014; Published December 11, 2014
Copyright:  2014 Chang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. Parameter files, model files, and example
scripts used to run the simulations presented in the paper can be found on FigShare. http://dx.doi.org/10.6084/m9.figshare.1201512.
Funding: This research was supported by National Institutes of Health grant DP1-HL123271 (http://www.nih.gov), the David C. Gakenheimer Fellowship, an
ARCS/MWC Scholar Award from the KPMG Foundation (http://www.arcsfoundation.org), and a scholarship from the Whitaker International Program (http://www.
whitaker.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: Natalia A. Trayanova is a
cofounder of CardioSolv, LLC. CardioSolv was not involved in this research.
* Email: ntrayanova@jhu.edu
Introduction
Atrial fibrillation (AF) is currently the most common cardiac
rhythm disorder, posing a significant medical and economic
challenge for the US health care system [1,2]. This burden is likely
to increase as the population ages and AF prevalence rises [3].
Effective prevention and treatment of AF depends upon advances
in our understanding of underlying disease mechanisms. Although
several features of AF electrophysiological remodeling have been
identified over the past decades [4,5], our knowledge about the
arrhythmogenic substrate remains incomplete.
Beat-to-beat alternation in the shape of cardiac electrical
signals, a phenomenon called alternans, has been observed in
the atria of AF patients, but the mechanism underlying these
alternans is not known [6–11]. Narayan et al. reported differences
in the rate dependence of action potential duration (APD)
alternans in patients, with APD alternans occurring at pacing
rates near rest in AF patients but only at fast pacing rates in
controls [8]. Narayan et al. also found that APD alternans always
preceded AF initiation, indicating that alternans may play an
important role in establishing the arrhythmogenic substrate and
creating vulnerability to AF. Thus, a better understanding of AF
arrhythmogenesis will likely depend upon identification of the
mechanism driving atrial alternans at heart rates near rest.
Interestingly, in AF patients the slope of the APD restitution
curve was ,1 during APD alternans onset at slow pacing rates.
This suggests that a cellular mechanism other than voltage-driven
instability underlies APD alternans at heart rates near rest [9].
Altered Ca2+ handling in atrial myocytes is known to play a crucial
role in the generation of AF triggers and in AF maintenance
[12,13]. Ca2+ cycling instabilities have been shown to underlie
ventricular alternans in heart failure [14,15], as well as atrial
alternans in several non-AF animal models [16–18]. However, it is
unknown whether these represent a plausible mechanism for atrial
alternans in AF patients, particularly at heart rates near rest. We
therefore sought to determine, using a computer model of human
atrial tissue, whether Ca2+ handling abnormalities, or other
electrophysiological changes that occur in AF, lead to APD
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alternans. We identified a critical change in the kinetics of the
ryanodine receptor (RyR) that was responsible for APD alternans
onset at slower pacing rates, and subsequently aimed to elucidate
the mechanistic relationship between this disruption in RyR
kinetics and alternans onset. To this end, we employed single-cell
clamping of ionic model parameters and iterated map analysis in
order to dissect the mechanisms which drive alternans in atrial
tissue, as well as to provide important insights into the
pathophysiological changes that contribute to the development
of alternans in AF patients.
Results
APD alternans in the human AF tissue model
In order to investigate ionic mechanisms in human AF that
contribute to the generation of atrial APD alternans at the tissue
level, we created a computer model of human atrial tissue
incorporating ionic remodeling associated with chronic AF (cAF),
as described in Methods. The sensitivity of APD alternans to ionic
model parameters was evaluated by varying parameters one at a
time and applying the clinical pacing protocol used by Narayan et
al. to induce APD alternans in AF patients [8] (see Table 1 and
Methods). For control, a model of normal human atrial tissue was
also simulated. We then assessed the magnitude and onset pacing
cycle length (CL) of APD alternans by analyzing voltage traces
from the recording electrode (Fig. 1A), as outlined in Methods.
In the control model, significant APD alternans did not occur
before loss of capture at 260 ms CL (Fig. 1B). However, in the
cAF-remodeled tissue preparation, significant APD alternans
appeared at a CL of 240 ms (Fig. 1B). Varying the RyR
inactivation rate constant (kiCa) had the greatest effect on alternans
onset CL in the human cAF-remodeled tissue (Fig. 2A). In fact,
only reduction of kiCa resulted in alternans onset at CLs of 300–
500 ms (Fig. 2B), matching alternans onset CLs observed in AF
patients [8]. When other ionic model parameters were varied from
their original cAF values, APD alternans either did not appear in
the tissue model at CL$300 ms (Fig. 2A, blue areas), appeared
only at CL#350 ms (Fig. 2A, red areas), or did not appear before
loss of capture or conduction block occurred in the tissue (Fig. 2A,
white spaces). These results suggest that altered RyR kinetics is the
critical cellular component underlying the occurrence of APD
alternans in AF patients at pacing rates near rest, and that kiCa
plays a key role in this process.
We also tested whether differences between left and right atrial
electrophysiology affect alternans susceptibility using a right
atrium (RA) version of the cAF model [19] in tissue simulations.
Results for RA tissue were very similar to those for the left atrium
(LA), demonstrating that modulation of kiCa could reproduce
alternans observed at pacing rates near rest in both the LA and
RA of AF patients [8] (S2 Figure).
When kiCa was decreased by 50% in the cAF model (we refer to
this as the cAFalt ionic model), APD alternans onset data from the
human AF tissue model agreed well with data from persistent AF
patients. Significant APD alternans began at 400-ms CL (Fig. 1B,
dotted red line), mean APD at onset was 229 ms, and APD
alternans magnitude at onset was 27 ms (Fig. 1C, dotted red line).
These metrics were each within one standard deviation (SD) of
clinical observations [8] (Fig. 3). The cAFalt model also displayed
noticeable alternans in intracellular Ca2+ ([Ca2+]i) at the onset CL
(Fig. 1D). For both the cAF and cAFalt models, mean APDs were
shorter than in the control model (Fig. 1B–C), and diastolic and
systolic [Ca2+]i were lower than in control (Fig. 1D). At 400-ms
CL in the cAFalt model, on the odd (long) vs. the even (short) beat
(Fig. 4, blue vs. red), there was higher sarcoplasmic reticulum (SR)
Ca2+ load before release (0.288 vs. 0.273 mM), higher peak RyR
open probability (RyRo) (9.0e-4 vs. 4.7e-4), a larger intracellular
Ca2+ transient (CaT) amplitude (D[Ca2+]i = 0.13 vs. 0.067 mM),
similar L-type Ca2+ (LCC) current (integrated over one beat: 144
vs. 140 mC/F), and increased Na+/Ca2+ exchanger (NCX)
current (INCX, integrated over one beat: 98.4 vs. 74.5 mC/F).
The positive coupling between transmembrane potential (Vm) and
Ca2+, with INCX as the primary electrogenic current, is consistent
with experimental findings [20]. Since the magnitude and onset of
APD alternans in the cAFalt model provided the best agreement
with clinical APD alternans data (Fig. 3), we chose to use this
model for subsequent investigations into the underlying causes of
alternans occurrence.
SR Ca2+ release underlies alternans onset
Since APD alternans throughout the homogenous cAFalt tissue
preparation were concordant and of similar magnitude (S3
Figure), electrotonic effects and CV restitution were excluded as
factors influencing these alternans. Indeed, APD and CaT
alternans in the cAFalt tissue model were very similar to alternans
in the isolated single-cell cAFalt model (Fig. 5, left column vs.
Fig. 4, top row). We therefore concluded that cellular mechanisms
gave rise to alternans in the cAFalt tissue model and decided to
utilize single-cell simulations in order to investigate these
mechanisms. We first used the ionic model variable clamping
protocol described in detail in Methods. The percent change in
APD and CaT alternans magnitudes, when each ionic model
variable was clamped to its trace from either the even (short) or
odd (long) steady-state beat at the alternans onset CL (400 ms), are
summarized in Fig. 6 (right column: state variables, left column:
currents and fluxes). Variables which resulted in .99% reduction
in APD and CaT alternans magnitudes for both even and odd beat
clamps were considered essential for alternans.
Clamping Vm resulted in 261.8% change in CaT alternans
magnitude for even beat clamps and +6.6% for odd beat clamps,
demonstrating that the alternans were not voltage-driven (see even
and odd beat clamps depicted in column 2 of Fig. 5 and S4 Figure,
respectively). Clamping [Ca2+]i enhanced APD alternans (+55.2%
and +75.8% for even and odd beat clamps, respectively, column 3
Author Summary
Atrial fibrillation is an irregular heart rhythm affecting
millions of people worldwide. Effective treatment of this
cardiac disorder relies upon our detailed knowledge and
understanding of the mechanisms that lead to arrhythmia.
Recent clinical observations have suggested that alternans,
a phenomenon where the shape of the electrical signal in
the heart alternates from beat to beat, may play an
important role in this process, but the underlying
mechanisms remain unknown. In this study, we use
computational models to conduct a detailed examination
of the causes and contributors to alternans associated with
human atrial fibrillation. We find that in atria remodeled by
atrial fibrillation, alternans appears near resting heart rates
because several aspects of calcium cycling are disrupted in
the atrial cells. In particular, the release and uptake of
calcium from the cellular storage compartment, the
sarcoplasmic reticulum, becomes imbalanced, leading to
alternation in calcium signals from beat to beat. These
findings provide important insights into the mechanisms
of proarrhythmic alternans in human atrial fibrillation
which may be used to develop novel therapeutic targets
and treatment strategies in the future.
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Table 1. Ionic model parameters used in parameter sensitivity analysis.
Parameter Description
gNa Maximal fast Na
+ current conductance
gNaL Maximal late Na
+ current conductance
gCaL Maximal L-type Ca
2+ current conductance
tf L-type Ca
2+ current voltage-dependent inactivation time constant
tfCa Maximal L-type Ca
2+ current calcium-dependent inactivation time constant
gK1 Maximal inward rectifier K
+ current conductance
gKr Maximal rapidly activating delayed rectifier K
+ current conductance
gKs Maximal slowly activating delayed rectifier K
+ current conductance
gKur Maximal ultrarapid delayed rectifier K
+ current conductance





2+ release rate constant
kim Transition rate constant for the RyR
kom Transition rate constant for the RyR
kiCa Baseline inactivation rate constant for the RyR without luminal SR Ca
2+ dependence
koCa Baseline activation rate constant for the RyR without luminal SR Ca
2+ dependence
kleak SR Ca
2+ leak rate constant
VmaxSRCaP Vmax of SERCA pump
ec50SR EC50 for luminal Ca
2+ dependence of the RyR
Kmf Km for SERCA pump in forward mode
doi:10.1371/journal.pcbi.1004011.t001
Fig. 1. Tissue preparation setup and comparisons of control, cAF, and cAFalt tissue during pacing. (A) Atrial tissue mesh with stimulus
and recording electrodes. (B) APD restitution curves for control tissue (black), cAF-remodeled tissue [19] (red), and cAFalt tissue with APD alternans
onset and amplitude matching clinical data [8] (dotted red line). The RyR inactivation rate constant (kiCa) was reduced 50% in the cAF model to create
the cAFalt model. APs (C) and CaTs (D) recorded from the last two beats at 400-ms pacing CL. Alternans are present in the cAFalt tissue but not in
control or cAF tissue.
doi:10.1371/journal.pcbi.1004011.g001
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of Fig. 5 and S4 Figure). However, when SR Ca2+ ([Ca2+]SR) was
clamped to either the even or odd beat waveforms, alternans in
both APD and CaT were eliminated (,299%), demonstrating
that the alternans were driven by SR Ca2+ instability (column 4 of
Fig. 5 and S4 Figure). In addition, four other variables could be
clamped to the even or odd beat waveforms to eliminate APD and
CaT alternans: RyR inactivated probability (RyRi), RyR open
probability (RyRo), junctional Ca
2+ ([Ca2+]j), and SR Ca
2+ release
flux (JSRCarel) (Fig. 6, and S5 and S6 Figures). All five of these
variables were therefore critical for enabling alternans to occur at
the onset CL. Furthermore, these variables directly impact SR
Ca2+ release, implicating SR Ca2+ release as the underlying source
of alternans in the cAFalt model.
There were two ionic model components which greatly reduced
but did not eliminate alternans when clamped: sub-sarcolemmal
Ca2+ ([Ca2+]sl) and sub-sarcolemmal Na
+/Ca2+ exchanger current
(INCXsl). Clamping [Ca
2+]sl to the even beat eliminated all
alternans; clamping to the odd beat greatly reduced APD and
CaT alternans (295.8% and 296.2%, respectively), although
large alternation in SR load persisted (Fig. 6 and columns 1–2 of
S7 Figure). Similarly, clamping INCXsl to the even beat waveform
resulted in elimination of APD but not CaT alternans (+72.9%),
while clamping to the odd beat waveform resulted in elimination
of all alternans (Fig. 6 and columns 3–4 of S7 Figure). Hence, the
SR Ca2+-driven instabilities produced alternans in Ca2+ cycling
which were positively coupled to voltage through INCXsl and
[Ca2+]sl.
Steepening of the SR Ca2+ release slope results in
alternans
Increased steepness of the SR release-load relationship is a well-
known mechanism for CaT alternans [21,22]. The importance of
SR Ca2+ release variables for APD and CaT alternans, as
demonstrated by the results in Fig. 5, 6, and S4, S5, S6 Figures,
Fig. 2. Sensitivity of APD alternans magnitude to ionic model parameters in cAF tissue. Parameter sensitivity analysis was performed in
cAF tissue in order to identify ionic model parameters that influence alternans. For panels A and B, APD alternans normalized magnitude (ANM) is
indicated by the colorbar (.0.05 considered significant). (A) Parameters were scaled one at a time between 25% (short ticks) and 200% (long ticks) of
their AF model values (25% increments). Only decreasing the RyR inactivation rate constant (kiCa) produced alternans at the longest CLs. (B) kiCa was
scaled between 25% and 100% in 5% increments, producing a range of APD alternans onset CLs between 300–750 ms.
doi:10.1371/journal.pcbi.1004011.g002
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led us to hypothesize that such a mechanism might give rise to
Ca2+-driven alternans in the cAFalt model at pacing rates near rest.
To test this, we compared the cAF and cAFalt ionic models under
action potential (AP) voltage clamp conditions so that changes in
CaT alternans would be due solely to changes in Ca2+ homeostasis
rather than bidirectional coupling between Vm and Ca
2+. After
clamping each ionic model at a CL of 400 ms until steady state
was reached, we perturbed [Ca2+]SR and tracked SR load and SR
Ca2+ release on the subsequent clamped beats (see Methods for
details). The SR release-load relationships for the cAF (black) and
cAFalt (red) ionic models are depicted in Fig. 7 (left column, row 1).
The slope of the release-load relationship in the cAFalt model
(m = 3.1) was much greater than the slope in the cAF model
(m = 1.7), confirming our hypothesis that differences between the
cAF and cAFalt ionic models led to a steepening of the SR Ca
2+
release slope.
To better explain the differences between the cAF and cAFalt
ionic models that gave rise to different SR Ca2+ release slopes, we
first compared [Ca2+]SR, RyRo, [Ca
2+]j, and cumulative Ca
2+
release for the two models at steady state (Fig. 7, left column, rows
2–5, solid lines). In the cAFalt model, [Ca
2+]SR at steady state was
19.7% lower than in the cAF model as a result of increased RyR
opening (Fig. 7, left column, rows 2 and 3, red vs. black solid lines).
Although this led to a 15.2% decrease in peak [Ca2+]j in the cAFalt
model, the duration of the release event was prolonged (Fig. 7, left
column, row 4, red vs. black solid lines). Consequently, though
cumulative Ca2+ release in the cAFalt model initially lagged
behind, at t<90 ms it actually surpassed the cumulative release in
the cAF model, ultimately resulting in a 3.4% increase in total
release by the end of the beat (Fig. 7, left column, row 5, red vs.
black solid lines).
To illustrate how these differences between the cAF and cAFalt
ionic models impacted SR release slope, we applied a large
perturbation to [Ca2+]SR (+20 mM) at the beginning of a clamped
beat and compared the unperturbed (steady state, solid line) and
perturbed (dotted line) traces for each model (Fig. 7, left column,
rows 2–6). Higher SR load at the beginning of the beat led to
increased SR release flux due to luminal Ca2+ regulation of the
RyR (causing more opening), as well as to the increased
concentration gradient between the SR and junctional compart-
ments. In both the cAF and cAFalt models, these changes led to
increased peak [Ca2+]j (+54.4% and +100%, respectively) and
RyR opening (+64.6% and +129%, respectively) as a result of
more Ca2+-induced Ca2+ release (Fig. 7, left column, rows 2–4).
The positive feedback relationship between [Ca2+]j and RyR
opening was strong enough such that when SR load was increased
(Fig. 7, left column, row 2, dotted vs. solid lines), this actually
resulted in a lower minimum [Ca2+]SR during release (23.6% and
213.3% for cAF and cAFalt models, respectively). However, the
amount of positive feedback differed between the cAF and cAFalt
ionic models. Positive feedback amplifies changes in release inputs,
such as SR load; therefore, in the cAF model, where [Ca2+]j is
higher and positive feedback is stronger, the increase in [Ca2+]SR
produced a slightly greater change in release (compared to the
Fig. 3. Comparison of alternans onset characteristics in
persistent AF patients and in the cAFalt tissue model. Mean6SD
alternans onset data during pacing in persistent AF patients (white
bars) was taken from Table 2 in Ref. [8]. When the cAFalt tissue model
was paced similarly, alternans onset CL, mean APD at onset, and APD
alternans magnitude at onset were within one SD of clinical data (gray
bars).
doi:10.1371/journal.pcbi.1004011.g003
Fig. 4. Alternans in cAFalt tissue at the onset CL. The odd (blue) and even (red) beats at the alternans onset CL (400 ms) are shown
superimposed. Large Ca2+ release occurred during the long beat (blue traces). Top (left to right): transmembrane potential (Vm), intracellular Ca
2+
([Ca2+]i), and SR Ca
2+concentration ([Ca2+]SR). Bottom (left to right): RyR open probability (RyRo), L-type Ca
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unperturbed, steady state simulation) during the rising phase of
[Ca2+]j (t,48 ms) than in the cAFalt model (Fig. 7, left column,
row 6, black vs. red).
By contrast, termination of release occurs through a negative
feedback process, with RyRs inactivating upon the binding of
junctional Ca2+. Negative feedback attenuates changes in release
so that robust, fast termination of release is achieved even when a
disturbance (such as a transient increase in SR load) occurs. In the
cAFalt model, negative feedback is decreased both directly, via
reduction of kiCa, and indirectly, via reduction in [Ca
2+]j that
occurs as a result of decreased SR load. This causes prolongation
of the Ca2+ release event and a larger peak [Ca2+]j (Fig. 7, left
column, row 4, red vs. black dotted lines). Consequently, when SR
load was increased by the same amount in the cAF and cAFalt
models, although the cAFalt model had a lesser initial change in
release because of weaker positive feedback, it also had a greater
final change in release, i.e. a steeper SR release-load relationship,
because of weaker negative feedback (Fig. 7, left column, row 6,
red vs. black).
The results in column 1 of Fig. 7 demonstrate how the steeper
SR release slope in the cAFalt ionic model (as compared to the cAF
ionic model) depends upon RyR inactivation by junctional Ca2+.
However, recent work suggests that termination of release does not
rely on direct Ca2+-dependent inactivation of the RyR but rather
on local SR Ca2+ depletion [23–26]. In order to test whether
steepening of the SR release slope could occur in the cAF model
by an alternative release termination mechanism, we implemented
a version of the cAF model in which the RyR Markov model was
replaced with that of Sato and Bers and the SR was divided into
junctional (JSR) and network (NSR) compartments [27] (see
Table 2 and S1 Text). Termination of release in this alternative
RyR model relies on calsequestrin (CSQN) binding to the RyR,
which occurs as luminal [Ca2+] decreases causing changes in RyR
opening and closing rates.
The effects of decreased RyR termination in the Sato-Bers RyR
model are shown in the right column of Fig. 7. When the CSQN-
bound RyR closing rate k34 (analagous to the inactivation rate kiCa
in the original model) is decreased from 100% to 50% (cAFalt),
steady-state Ca2+ concentrations change modestly as compared to
the original RyR formulation (Fig. 7, black vs. red solid lines), but
nevertheless display similar trends: [Ca2+]JSR decreases by 1.5%
(vs. 19.7%, row 2), peak [Ca2+]j is reduced by 10.5% (vs. 15.2%,
row 4) and delayed, and total release increases by 3.6% (vs. 3.4%,
row 5). When [Ca2+]NSR is perturbed in the Sato-Bers models by +
20 mM, Ca2+ release increases more in the cAFalt model than in
the cAF model (Fig. 7, right column, row 6, red vs. black dotted
lines). Consequently, the SR Ca2+ release slope is steeper in the
cAFalt model (m = 3.7 vs 1.9, Fig. 7, right column, row 1). Thus,
although changes in SR Ca2+ release slope in the original cAF
model are caused by altered junctional Ca2+-dependent inactiva-
tion, altered SR Ca2+-dependent mechanisms of release termina-
tion can produce such changes in SR Ca2+ release slope as well.
Fig. 5. Voltage and Ca2+ even beat clamps for the single-cell cAFalt model. Traces of transmembrane potential (Vm, row 1), intracellular Ca
2+
([Ca2+]i, row 2), and SR Ca
2+ ([Ca2+]SR, row 3) from two consecutive beats are superimposed to show alternans between even (red) and odd (blue)
beats. Column 1: the unclamped cAFalt cell paced to steady state at 400-ms CL displayed alternans in Vm and Ca
2+. The red traces depicted in column
1 were used to clamp Vm (column 2), [Ca
2+]i (column 3), or [Ca
2+]SR (column 4). Alternans persisted when Vm or [Ca
2+]i is clamped, but clamping
[Ca2+]SR eliminated alternans.
doi:10.1371/journal.pcbi.1004011.g005
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Fig. 6. Summary of ionic model variable clamps for the single-cell cAFalt model. Results for all ionic model variable clamping simulations
are summarized in bar graphs showing the percent changes in APD and CaT alternans magnitudes when model variables were clamped to even or
odd beat waveforms. Alternans were eliminated (.99% decrease in APD and CaT alternans magnitudes for both even and odd beat waveforms) only
when SR release variables were clamped (SR Ca2+ release flux, JSRCarel; RyR open probability, RyRo; RyR inactivated probability, RyRi; SR Ca
2+ ([Ca2+]SR);
and junctional Ca2+([Ca2+]j). Gating variable f (asterisk) displayed higher order instability when clamping to the even beat waveform, so the increase in
alternans magnitude was considered infinitely large. Left column: SR fluxes and sarcolemmal currents. Right column: state variables.
doi:10.1371/journal.pcbi.1004011.g006
Calcium Release and Atrial Alternans Associated with Human AF
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Fig. 7. The effect of RyR inactivation on SR Ca2+ release slope. Left column: simulations using the original cAF (black) and cAFalt (red) models.
Right column: simulations in which the original RyR model, which included Ca2+-dependent inactivation, was replaced with the Sato-Bers RyR model,
which utilizes calsequestrin regulation instead (see Table 2). In the Sato-Bers model, the SR is divided into junctional (JSR) and network (NSR)
compartments. Top row: Total Ca2+ released from the SR is plotted against SR Ca2+ load under AP voltage clamp conditions (CL = 400 ms). The line of
best fit is also plotted, with its slope value (the SR Ca2+ release slope) shown next to the data points. (In column 2, the first beat was excluded.)
Modulating RyR inactivation by reducing kiCa (left column) or k34 (right column) by 50% increased the SR Ca
2+ release slope in both models. Rows 2–
6: Traces from a similar set of AP voltage clamp simulations. After reaching steady state (solid lines), SR or NSR load was perturbed at the beginning of
Calcium Release and Atrial Alternans Associated with Human AF
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Iterated map analysis
Although SR Ca2+ release slope is an important component of
Ca2+ homeostasis, other aspects of Ca2+ cycling, such as SR Ca2+
uptake, could also have a significant impact. In order to
understand how both SR release and uptake contribute to CaT
alternans onset at slow pacing rates in human cAF cells, we used
an iterated map analysis for investigating Ca2+ cycling stability
under AP voltage clamp conditions. Three factors affecting Ca2+
cycling stability were included in the analysis: SR release, SR
uptake, and cellular Ca2+ flux across the sarcolemma. The latter
factor was included because Ca2+ content in the human atrial cell
model varied significantly enough to affect alternans threshold
predictions.
For each version of the human atrial cell model (cAF and
control), we calculated the SR Ca2+ release slope (m), the SR Ca2+
uptake factor (u), and the cellular Ca2+ efflux factor (k) [28,29] for
a range of kiCa values and pacing rates and compared the value of
m to the threshold for alternans. For a typical range of parameter
values (uzkv1, see S1 Text), the threshold value of m required





Theoretical analysis predicts that the system is stable when
mvmthresh. Eq. 1 is graphed for a range of k values in Figs. 8A–C
(dotted lines). Each curve represents the boundary between stable
(no alternans) and unstable (alternans) Ca2+ cycling in the u-m
plane for a particular value of k. As k increases (Fig. 8A–C, dark
blue to dark red), the threshold curve steepens, indicating that
increased Ca2+ extrusion from the cell has a protective effect,
helping to restore Ca2+ content back to steady state following a
perturbation. Thus, a higher value of m is required to reach
alternans threshold for higher values of k. Note that in this
theoretical approach, increased Ca2+ efflux (k) has the opposite
effect as in Qu et al. [29], suppressing rather than promoting Ca2+
alternans.
The effects of changing CL and changing kiCa are explored for
the cAF model in Fig. 8A. At the default kiCa value (100%), as CL
is decreased from 700 ms to 200 ms (210 ms increments), u
decreases, m increases, and the system approaches the alternans
threshold given by Eq. 1. The change in k values is non-
monotonic, initially decreasing (orange to green) and then
increasing (green to orange) as CL is decreased. However, the
change in k has a minimal effect at small u values, since the
threshold curves for different k values converge at u~0. At CL,
220 ms, the cell begins to display alternans in Ca2+ cycling,
coinciding with the iterated map parameter values residing very
close to the theoretically predicted boundary given by Eq. 1
(Fig. 8A, orange X’s). When kiCa is set at 50% of the default cAF
value (cAFalt model), a similar trend is observed. However, the
50% kiCa cAF model reaches threshold at a lower pacing rate
(CL = 390 ms for the 50% kiCa cAF model vs. 210 ms for the
100% kiCa cAF model, Fig. 8A, X’s). This is primarily due to m
increasing as kiCa is decreased, illustrated by the trajectory of the
system in the u-m plane as CL is held constant at 390 ms but kiCa
is decreased from 100% to 50% (Fig. 8A).
We next performed the same iterated map analysis for the
control atrial cell model with varying CL and kiCa values (Fig. 8B).
When kiCa is at 100%, u decreases as CL is decreased. However,
unlike in the cAF model, in the control case the value of m
undergoes a net decrease as CL shortens from 700 to 200 ms.
Ultimately, since both m and u decrease as CL is shortened, the
control atrial cell (with kiCa at 100%) fails to reach threshold and
remains in the stable, no alternans region. This suggests that
alternans in control patients, which occur at CL,250 ms [8], are
driven by voltage rather than Ca2+. As in the cAF model, the
alternans threshold CL in the control model can be adjusted by
modulating the value of kiCa (Fig. 8B, CL = 390 ms). However, in
the control model, kiCa must be decreased much more than in the
the beat by a large amount (+20 mM, dashed lines) to illustrate the changes affecting SR Ca2+ release slope. Row 2: SR (JSR) Ca2+ ([Ca2+]SR/JSR). Row 3:
RyR open probability (RyRo). Row 4: junctional Ca
2+ ([Ca2+]j). Row 5: total Ca
2+ released. Row 6: the difference in total Ca2+ release between perturbed
and unperturbed (steady state) simulations. Insets in column 2, rows 3–4 show traces from t = 0–50 ms.
doi:10.1371/journal.pcbi.1004011.g007
Table 2. RyR and SR parameters.
Parameters Original cAF value [19]
Value used in replacement of RyR with Sato-Bers
model [27] Description
koCa 30 mM
22 ms21 N/A RyR opening rate
Ku N/A 15 ms
21 CSQN-unbound RyR opening rate
Kb N/A 0.015 ms
21 CSQN-bound RyR opening rate
tb N/A 0.164 ms CSQN binding time constant
tu N/A 312 ms CSQN unbinding time constant
ttr N/A 5 ms JSR refilling time constant
VSR/Vcell 0.035 N/A SR fractional volume
VJSR/Vcell N/A 0.0035 JSR fractional volume
VNSR/Vcell N/A 0.0315 NSR fractional volume
VmaxSRCaP 5.31610
23 mM/ms 5.0461022 mM/ms Vmax of SERCA pump
ks 25 ms
21 134 ms21 SR Ca2+ release rate constant
Bmax_csqn 2.6 mM 0.4 mM CSQN concentration
KC 0.65 mM 0.6 mM Ca
2+/CSQN dissociation constant
doi:10.1371/journal.pcbi.1004011.t002
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cAF model in order to reach mthresh at a CL of 390 ms (kiCa
reduced to 16% vs. 50%). The need for dramatic and possibly
unrealistic reductions in kiCa to produce alternans at slow rates in
control is consistent with the absence of alternans observed in
control patients at CL$250 ms [8].
To explain the difference in Ca2+ cycling properties of the cAF
and control models, we examined the effects of cAF cellular
remodeling on iterated map parameters. Stochastic ionic model
parameter variation and regression analysis [30] (see S1 Text)
predicted that of the ten model parameters altered in the control
model to construct the cAF model, seven would have significant
effects on alternans threshold CL (these are gCaL, gKur, koCa,
IbarNCX, gto, gK1, and gNa, see S8 Figure). Of these seven
parameters, three are involved in Ca2+ handling (gCaL, koCa, and
IbarNCX). The effects of changing these three parameters from
control to cAF values is depicted sequentially in Fig. 8C: starting
with the default values for the control cell at a CL of 390 ms, first
gCaL is decreased and then IbarNCX and koCa are increased to cAF
values, resulting in an overall decrease in u and m. Finally, when
kiCa is decreased to the cAFalt value (50%), the large increase in m
causes the system to reach mthresh and alternate (Fig. 8C, red X).
This illustrates why the control cell is less susceptible to CaT
alternans than the cAF cell: at a given kiCa value and pacing rate,
SR uptake efficiency (u) is higher in the control model, thus
requiring a large increase in the pacing rate (which decreases u)
and/or a large decrease in kiCa (which increases m) in order to
reach mthresh. Of the three cAF parameters which decrease u,
however, gCaL is the most important for alternans onset, since
remodeling of IbarNCX and koCa decreases m, while remodeling of
gCaL increases m. When gCaL is remodeled and IbarNCX and koCa
remain at control values, only a 28% decrease in kiCa is required to
reach mthresh (Fig. 8C, green X).
Fig. 8. Iterated map analysis of Ca2+ cycling in cAF and control cells. For each panel, SR Ca2+ release slope (m) is plotted against SR Ca2+
uptake factor (u), with cellular Ca2+ efflux factor (k) values indicated in the color bar. The boundaries between stable (no alternans) and unstable
(alternans) regions in the u-m plane are denoted by dashed lines for different values of k (see Eq. 1). Circles and X’s indicate the absence and presence
of alternans, respectively. (A) Results for the cAF model. CL is varied, from 700 ms to 200 ms for the 100% kiCa model and from 700 ms to 300 ms for
the 50% kiCa model (i.e., the cAFalt model), in 10-ms increments. At a CL of 390 ms, kiCa is scaled from 100% to 50% in 2% increments. (B) Same as in
panel A, except that the control cell model is used, and kiCa is scaled from 100% to 16%. (C) Starting with the control cell parameter values, L-type
Ca2+ current conductance (gCaL), maximal Na
+/Ca2+ exchanger current (IbarNCX), and RyR activation rate constant (koCa) are sequentially scaled to cAF
values, resulting in net decreases in m and u. Finally, kiCa is scaled to 50% (as in the cAFalt model), and m increases sufficiently to reach the alternans
boundary (red X). If only gCaL is decreased to the cAF value, then alternans threshold is achieved at a higher kiCa value (72%, green X).
doi:10.1371/journal.pcbi.1004011.g008
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Discussion
Findings and significance
The first goal of this study was to identify the electrophysiolog-
ical changes in human atrial cells that are responsible for the
occurrence of APD alternans at heart rates near rest, as observed
in AF patients. Using parameter sensitivity analysis, we found that
of the 20 electrophysiological model variables tested, only changes
in the RyR inactivation rate constant (kiCa) could produce APD
alternans at relatively slow pacing rates in a tissue model of
persistent/chronic AF. In particular, decreasing kiCa by 50% (the
cAFalt model) produced a good match to clinical data. We next
aimed to provide mechanistic insight into why disruption of RyR
kinetics, together with other electrophysiological changes occur-
ring in AF, leads to alternans onset at pacing rates near rest. We
established that alternans in the cAFalt model at the onset CL were
Ca2+-driven rather than voltage-driven, and that they depended
upon SR Ca2+ release. Furthermore, CaT alternans occurred in
the cAFalt model at relatively long CLs because of steep SR Ca
2+
release slope and decreased SR Ca2+ uptake efficiency. Lastly, we
demonstrated that the ability to generate alternans at slower
pacing rates by modulating kiCa depended upon the negative
feedback properties of SR Ca2+ release.
This study is the first to identify a possible mechanism for
alternans occurring at slow heart rates in AF patients. Our novel
findings show that alternans at slow rates is Ca2+-driven, brought
about by AF-associated remodeling of the Ca2+ handling system in
atrial cells. Clinical and experimental research has shown that
atrial alternans is associated with disease progression in AF
patients [8] and with increased AF susceptibility after myocardial
infarction [31,32] and atrial tachycardia [33,34] in animal models.
Additionally, CaT alternans have been studied in animal atrial
myocytes [17,18,35] and in the intact atria of AF-prone mice [36].
However, the precise cellular mechanism underlying alternans at
heart rates near rest in the remodeled human atria has not been
previously identified, and a direct relationship between human AF
and CaT alternans in the atria has not been established until now.
Elucidating the mechanism driving alternans at slow rates is
particularly important because APD oscillations appear to be
closely linked to AF initiation [8]. If APD alternans play a direct
role in AF initiation, the onset of alternans at slower pacing rates
would indicate an increased susceptibility to arrhythmia in AF
patients, consistent with clinical observations [8]. Identification of
this mechanism would thus provide a significant scientific and
clinical benefit, improving our understanding of arrhythmogenesis
and aiding in the development of new targeted therapies for AF.
In this study, we demonstrate how different aspects of AF
remodeling contribute to Ca2+-driven alternans onset at slower
heart rates using a theoretical analysis of Ca2+ cycling. This
analysis allowed us to quantitatively assess CaT alternans
threshold under AP voltage clamp conditions in a detailed
electrophysiological model, providing valuable insights into the
effects of AF electrophysiological remodeling on Ca2+ handling
and alternans. Furthermore, we identify a critical aspect of SR
Ca2+ release—inactivation of the RyR—which is necessary for
CaT alternans to occur at slow heart rates. These findings extend
mechanistic insight about proarrhythmic ventricular Ca2+ remod-
eling [15,37,38] to the atria and may inform new therapeutic
strategies to target the RyR and suppress Ca2+-driven alternans in
the atria for the purposes of preventing or treating AF [36,39].
RyR dysregulation in AF
The RyR has been the focus of several studies concerning
trigger-mediated AF. In particular, disruption of RyR regulation
has been shown to promote AF through increased RyR open
probability, diastolic SR Ca2+ leak, and delayed afterdepolariza-
tions [12,39,40]. Here we identify an additional pathological
consequence of the disruption of RyR regulation in AF: Ca2+-
driven alternans. Similar to what has been demonstrated with
regards to Ca2+ sparks and triggered activity [39], we found that
CaT alternans is coupled to voltage primarily through upregulated
INCX, thus driving the generation of APD alternans. The RyR’s
central role in both alternans and triggers has important clinical
implications, given the proarrhythmic consequences of interaction
between ectopic activity and the arrhythmogenic substrate created
by voltage alternans [41]. New drug treatments to restore the
normal function of the RyR and NCX, and thereby prevent
arrhythmogenic triggers and alternans, have the potential to
provide more effective alternatives to current AF drug therapies
which target voltage-gated ion channels and often have proar-
rhythmic side effects [39].
The signaling pathways involved in RyR dysfunction in AF
have been the focus of much active research over the past several
years [39,40]. Possible molecular mechanisms which could
account for reduced RyR inactivation include RyR hyperpho-
sphorylation by CAMKII and PKA and dissociation of the RyR
subunit FKBP12.6, which have been shown to increase RyR open
probability and promote arrhythmia [42], although the exact role
of these mechanisms in RyR dysregulation are still debated [43].
Calmodulin has also been shown to interact directly with the RyR
to decrease its open probability [44]. Metabolic factors may play a
role, since modulation of the RyR as a result of glycolytic
inhibition has been linked to atrial alternans in non-AF animal
models [16,17,35]. Such metabolic impairment is thought to
contribute to profibrillatory remodeling in the atria [45–47]. The
cAFalt model, with its reduction in kiCa, can be considered a
phenomenological representation of the various signaling pathway
disruptions leading to alternans, which were not represented in the
original cAF model. As more information becomes available,
incorporation of these signaling mechanisms into computational
models may provide additional insights into how reduction in RyR
inactivation leads to Ca2+-driven alternans at slow heart rates in
AF patients.
The role of RyR refractoriness in CaT alternans
There is debate over whether CaT alternans depend primarily
on SR Ca2+ load alternation or on RyR refractoriness [21,41,48].
Recent experiments [18,49] and simulation studies [50–53] have
shown that RyR refractoriness can drive CaT alternans under
conditions where near-identical SR loads produce different
amounts of SR release. In some simulation studies, this
phenomenon was restricted to limited parameter values, clamping
conditions, and cycle lengths [51,52], while in a more recent
modeling study focusing on atrial cells, SR load-independent
alternans occurred over a broad range of pacing rates when the
number of t-tubules was reduced [53]. Of note is the fact that
many of these studies [51–53] utilized the same RyR gating
scheme as this current study, yet they identified various
mechanisms for CaT alternans. This demonstrates that the
relative importance of the various mechanisms, whether SR
load-driven, RyR refractoriness-driven, or otherwise, is highly
context-dependent.
Although exploring the issue of SR load vs. RyR refractoriness
was beyond the goals of the current study, our results suggest that
in human cAF, both SR load alternation and RyR refractoriness
are involved in alternans genesis at slower pacing rates. In our
cAFalt model, alternation in all SR Ca
2+ release variables,
including [Ca2+]SR, RyR open probability, and RyR inactivated
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probability, was necessary for alternans at the onset CL of 400 ms
(Fig. 6). In addition, SR uptake flux (Jserca) enhanced alternans
when clamped (Fig. 6) and therefore suppressed alternans under
normal pacing conditions, suggesting that SR load is indeed an
important driver of CaT alternans in cAF and that upregulation of
the SERCA pump may be an important therapeutic strategy for
diminishing alternans. We also showed that CaT alternans
occurred in the cAFalt model at slow pacing rates because
decreased RyR inactivation resulted in steepening of the SR
release-load relationship. Together, these results indicate that the
interplay between SR load and RyR kinetics is responsible for
alternans onset in human AF.
Other potential mechanisms for alternans susceptibility
The mechanisms for human atrial alternans susceptibility are
likely to encompass a range of complex interactions at multiple
scales of biology, which extend beyond the cellular-level mecha-
nisms found here. In this study we examined the behavior of an
atrial cell with well-developed t-tubules [19]. Research has shown
that rat atrial cells have variable levels of t-tubule organization
[54]. Such variation, if present in human atrial cells, would result
in subcellular Ca2+ gradients which could make cells more
susceptible to alternans [17,55,56]. Models of atrial myocytes
incorporating detailed spatial descriptions [57] and local control of
Ca2+ [58] will aid in future investigations of the subcellular
mechanisms of cAF-related alternans.
In addition, the complex structure of the atria, including its
normal conduction pathways [59] and fibrotic remodeling in AF
[60,61], may promote heterogeneity and discordant alternans,
which significantly affect alternans dynamics and reentry initiation
[9,62]. Consideration of these factors in the future will further
enrich the mechanistic insight gained from this current study and
will advance our understanding of the role that alternans play in
AF arrhythmogenesis.
Limitations
In many cell models, the effective refractory period (ERP) is not
consistent with ERP at the tissue level [63]. Electrotonic effects in
tissue and the whole heart can shorten or lengthen APD
depending on which structures and cell types are coupled to each
other. Furthermore, alternans in single cell models may not be
predictive of alternans in tissue, where conduction alternans can
occur. This was the case for the control atrial tissue model, in
which loss of capture occurred at a CL of 260 ms before reaching
the very fast pacing rates at which APD alternans were observed in
human control patients (CL = 218630 ms) [8]. However, alter-
nans onset at clinically observed rates occurred in the single-cell
control model (200 ms CL, S9 Figure, black curve) and when kiCa
was reduced by 5% (230 ms CL, S9 Figure, red curve). This
suggests that the ionic model may not be well-constrained for
tissue simulations at very fast rates. However, this issue did not
affect the study of alternans onset at slower pacing rates, as was
observed in AF patients.
Our ionic model variable clamping protocol, which involved
separately clamping the even or odd beat waveforms, was used to
test for model variables which could robustly suppress alternans
when clamped to either of two very different waveforms. An
alternative approach would be to clamp model variables to the
single unstable, non-alternating waveform obtained using a control
algorithm [64]. This approach would allow more precise
assessment of fixed point stability, since clamping is done at the
point of instability rather than during the bistable (alternans)
endpoint. However, for the purposes of quantifying the most
important variables influencing instability, the clamping protocol
used in this study was sufficient to identify the central role of SR
Ca2+ release, which was later confirmed through iterated map
analysis.
Recent experimental evidence points towards local SR Ca2+
depletion, rather than Ca2+-dependent RyR inactivation, as the
main mechanism of SR release termination [23–26]. Although
alternans in the cAFalt model relied on Ca
2+-dependent RyR
inactivation, other termination mechanisms which rely on SR
Ca2+ (used in the Sato-Bers RyR model) may have similar effects
on SR release slope and alternans susceptibility (Fig. 7, column 2).
However, with the Sato-Bers RyR model, alternans and other
complex oscillations began at the baseline pacing rate (750 ms CL,
S10 Figure) and did not display the same rate dependence
observed in patients [8]. In addition, large oscillations in CaT
amplitude did not couple as strongly to voltage as with the original
RyR, and oscillations were also attenuated in tissue (S10 Figure).
Further work is needed to develop atrial cell models which
incorporate current mechanistic understanding of SR Ca2+ release
and which can also reproduce AF-related alternans rate depen-
dence in tissue.
Conclusion
AF is associated with progressive changes in alternans onset in
the human atria, with alternans occurring at slower heart rates as
AF severity worsens. We found that the differences in alternans
onset between AF and control patients could be accounted for by
changes in the inactivation rate of the RyR in a model of human
atrial cAF-remodeled tissue. Single-cell simulations revealed that
alternans at these slow heart rates were driven by abnormal Ca2+
handling and the development of CaT alternans, and that changes
in CaT alternans threshold resulted from steepening of the SR
Ca2+ release slope, decreased SR Ca2+ uptake efficiency, and
decreased inactivation of the RyR. These findings provide
important insight into the mechanisms underlying proarrhythmic
APD alternans occurring at slow heart rates in cAF patients. Such
insight may aid in the development of targeted therapies and new
treatment strategies for AF in the future.
Methods
Human AF tissue model
In order to investigate ionic mechanisms in human AF that
contribute to the generation of atrial alternans at the tissue level,
we created a computer model of human atrial tissue incorporating
ionic remodeling associated with cAF. The atrial tissue prepara-
tion had dimensions of 0.3360.3369.9 mm3 (Fig. 1A), similar to
the one used by Krummen et al. [65] Human atrial cell membrane
kinetics were represented by a modified version of the Grandi-
Pandit-Voigt (GPV) human atrial action potential model [19],
which we refer to as the GPVm model. Detailed explanation and
justification of the GPVm model modifications are provided in the
supplement (S1, S2 Texts). Different types of human atrial tissue
were modeled individually as homogenous tissue preparations,
with each incorporating ionic changes appropriate for each tissue
type. Both control and cAF-remodeled tissue, as well as left and
right atrial tissue, were modeled using the parameter changes
specified by Grandi et al. [19] (see S1 Text). The isotropic bulk
conductivity value for the tissue was tuned to produce a
conduction velocity of 0.62 m/s in control tissue [59,66]. When
cAF ionic remodeling was incorporated, the same bulk conduc-
tivity value produced a conduction velocity of 0.59 m/s. These
values are within the reported ranges for control and AF
conduction velocities [67].
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Protocols for evaluating alternans in the human AF tissue
model
We assessed alternans in the human AF tissue model by
applying the clinical pacing protocol used by Narayan et al. to
induce alternans in AF patients [8]. The tissue model was first
initialized at all nodes with steady-state values from a single cell
paced at 750-ms CL. The tissue was then paced from the stimulus
electrode (Fig. 1A) for 20 beats at 750-ms CL and then for 74
beats at each subsequent CL, starting from 500 ms and shortened
in 50-ms steps to 300 ms, and then shortened in 10-ms steps, until
loss of capture or conduction block occurred.
Voltage traces from the recording electrode (Fig. 1A) were
analyzed for APD alternans. APD was calculated as the time from
maximal upstroke velocity to 90% repolarization of Vm from
phase II amplitude. Alternans magnitude was quantified as the
mean magnitude of change in APD over the last 10 pairs of beats
(11 beats total). APD alternans normalized magnitude (ANM),
obtained by dividing the alternans magnitude by the mean APD
over the last 10 beats, was used to compare alternans between cells
of varying APD. Alternans onset CL was defined as the longest CL
for which ANM was greater than 5% [8].
Sensitivity of alternans to ionic model parameters
To identify cellular changes which could account for the onset
of alternans in AF patients at CLs of 300–500 ms [8], we
explored how ANM varied in human AF tissue models of both
the left and right atrium as a result of changes in ionic model
parameters. Of the 20 ionic model parameters tested, 10 were
parameters altered in the GPVm model to represent cAF [19];
others were associated with L-type Ca2+ current (ICaL), rapidly
activating potassium current (IKr), SR uptake, or SR release
(Table 1). We scaled parameter values one at a time to 25–200%
of the default left or right atrium values specified by Grandi et al.
[19]; for each parameter value within this range, simulations were
conducted to determine the presence of alternans (282 simula-
tions total). In AF patients, average alternans onset CL was.
300 ms [8], so pacing and alternans analysis was restricted to
CLs$300 ms.
Clamping protocols
After identifying conditions under which APD alternans
magnitude and onset CL matched clinical observations, we
utilized two different clamping approaches in order to investigate
the key cellular properties that gave rise to these alternans, as
described below. Further explanation of the rationale behind these
methods can be found in Results.
Ionic model variable clamps. To determine which human
atrial ionic model variables drive the occurrence of alternans, we
clamped individual ion currents and state variables in a single-cell
model paced at a CL exhibiting alternans [15]. A model variable
was clamped to its steady-state even or odd beat trace for the
duration of 50 beats. This procedure was repeated for different
model variables (membrane currents, SR fluxes, and all state
variables excluding buffer concentrations), and APD alternans
magnitude was quantified at the end of the 50 clamped beats.
Additionally, the magnitude of alternans in D[Ca2+]i was
quantified in the same manner as APD alternans magnitude, with
D[Ca2+]i calculated as the difference between peak [Ca
2+]i during
the beat and minimum [Ca2+]i during the preceding diastolic
interval (DI). Model variables were considered critical for
alternans if clamping them to either the even or odd beat reduced
both APD and CaT alternans magnitudes by .99% of baseline
[15].
AP clamp. To evaluate the Ca2+ cycling properties of the
human atrial cell model under different pacing rates and
parameter values, the following equation was used to clamp Vm
to a generic atrial AP-like waveform so that comparisons between








This approach has been used previously to investigate Ca2+ cycling
properties in ventricular myocyte models [22,50]. We set
Vmax = 10 mV, Vrest = 275 mV, and APD = 200 ms. CL ranged
from 200 to 700 ms.
The AP clamp enabled evaluation of Ca2+ cycling stability in
the human atrial cell model via an iterated map analysis
[22,28,68]. We used a similar approach as Qu et al. [29], where
SR load and total Ca2+ content of the cell are tracked from beat to
beat. In our analysis, Ca2+ cycling stability depended upon three
iterated map parameters: SR Ca2+ release slope (m), SR Ca2+
uptake factor (u), and cellular Ca2+ efflux factor (k). A detailed
derivation of the iterated map stability criteria can be found in S1
Text.
To compute the iterated map parameters, a single atrial cell was
repeatedly clamped to the AP waveform until model variables
reached steady state. Following this, [Ca2+]SR was perturbed by
61% at the beginning of an even beat, and total SR load, release,
uptake, and cellular Ca2+ efflux per beat were recorded for the
following 10 beats. For the Sato-Bers model, the first beat was
excluded since it deviated noticeably from the linear response of
later beats. This procedure was repeated starting with an odd beat
so that data from a total of 40 beats were recorded (36 beats for the
Sato-Bers model). Lastly, m, u, and k were computed as the slopes
of the linear least-squares fit of the data (see S1 Text).
Numerical methods
The monodomain and ionic model equations were solved using
the Cardiac Arrhythmia Research Package (CARP; Cardiosolv,
LLC) [69]. Details on the numerical techniques used by CARP
have been described previously [70,71]. A time step of 20 ms was
used for all simulations.
Supporting Information
S1 Figure Comparison of original and modified ver-
sions of the GPV ionic model in tissue. At 400-ms CL, the
original GPV model did not propagate robustly in tissue (black
line). When the fast sodium current kinetics was replaced with the
kinetics from the Luo-Rudy dynamic model (LRd), normal
propagation occurred (blue line). Applying the fast equilibrium
approximation to select buffers (see S2 Text) had a negligible effect
on simulation results (dotted green line).
(TIF)
S2 Figure Sensitivity of APD alternans magnitude to
ionic model parameters in RA cAF tissue during pacing.
Parameter sensitivity analysis was performed in tissue with the
right atrium version of the GPVm model incorporating cAF
remodeling, in order to identify ionic model parameters that
influence alternans. APD alternans normalized magnitude (ANM)
is indicated by the colorbar (.0.05 considered significant).
Parameters were scaled one at a time between 25% (short ticks)
and 200% (long ticks) of their AF model values (25% increments).
Results were similar to those obtained with the left atrium version
of the model (see Fig. 2A), with alternans occurring at the longest
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CLs only when the RyR inactivation rate constant (kiCa) was
decreased.
(TIF)
S3 Figure APD alternans magnitudes in cAFalt tissue.
The tissue preparation was paced from the stimulus electrode (see
Fig. 1A), and APD alternans normalized magnitudes (ANMs) were
quantified at each cycle length for every node along the tissue.
When significant alternans was present in the tissue (ANM.0.05),
all nodes had concordant alternans of similar magnitude.
(TIF)
S4 Figure Voltage and Ca2+ odd beat clamps for the
single-cell cAFalt model. Traces of transmembrane potential
(Vm, row 1), intracellular Ca
2+ ([Ca2+]i, row 2), and SR Ca
2+
([Ca2+]SR, row 3) from two consecutive beats are superimposed to
show alternans between even (red) and odd (blue) beats. Column 1:
the unclamped cAFalt cell paced to steady state at 400-ms CL
displayed alternans in Vm and Ca
2+. The blue traces depicted in
column 1 were used to clamp Vm (column 2), [Ca
2+]i (column 3),
or [Ca2+]SR (column 4). Alternans persisted when Vm or [Ca
2+]i
was clamped, but clamping [Ca2+]SR eliminated alternans.
(TIF)
S5 Figure SR Ca2+ release parameter even beat clamps
for the single-cell cAFalt model. Traces of transmembrane
potential (Vm, row 1), intracellular Ca
2+ ([Ca2+]i, row 2), and SR
Ca2+ ([Ca2+]SR, row 3) from two consecutive beats are
superimposed to show alternans between even (red) and odd
(blue) beats. Traces from the even beat at 400-ms CL pacing were
used to clamp the relevant variable and are shown in row 4.
Clamping RyR inactivated probability (RyRi, column 1), RyR
open probability (RyRo, column 2), junctional Ca
2+ ([Ca2+]j,
column 3), or SR Ca2+ release flux (JSRCarel, column 4) eliminated
alternans in Vm and Ca
2+.
(TIF)
S6 Figure SR Ca2+ release parameter odd beat clamps
for the single-cell cAFalt model. Traces of transmembrane
potential (Vm, row 1), intracellular Ca
2+ ([Ca2+]i, row 2), and SR
Ca2+ ([Ca2+]SR, row 3) from two consecutive beats are
superimposed to show alternans between even (red) and odd
(blue) beats. Traces from the odd beat at 400-ms CL pacing were
used to clamp the relevant variable and are shown in row 4.
Clamping RyR inactivated probability (RyRi, column 1), RyR
open probability (RyRo, column 2), junctional Ca
2+ ([Ca2+]j,
column 3), or SR Ca2+ release flux (JSRCarel, column 4) eliminated
alternans in Vm and Ca
2+.
(TIF)
S7 Figure Sub-sarcolemmal parameter clamps for the
single-cell cAFalt model. Traces of transmembrane potential
(Vm, row 1), intracellular Ca
2+ ([Ca2+]i, row 2), and SR Ca
2+
([Ca2+]SR, row 3) from two consecutive beats are superimposed to
show alternans between even (red) and odd (blue) beats. Traces
from the even or odd beat at 400-ms CL pacing were used to
clamp the relevant variable and are shown in row 4. Clamping
sub-sarcolemmal Ca2+ ([Ca2+]sl) to the even beat (column 1)
eliminated alternans in Vm and Ca
2+, but clamping [Ca2+]sl to the
odd beat (column 2) produced small alternans in Vm and [Ca2+]i
and large alternans in [Ca2+]SR. Clamping sub-sarcolemmal Na
+/
Ca2+ exchanger current (INCXsl) to the even beat (column 3)
eliminated alternans in APD but produced large alternans in
[Ca2+]i and [Ca
2+]SR. Clamping INCXsl to the odd beat (column 4)
eliminated alternans in Vm and Ca
2+.
(TIF)
S8 Figure Multivariable regression between ionic mod-
el parameters and alternans threshold CL. (A) Bar graph
of regression coefficient magnitudes. Twenty ionic model param-
eters were varied stochastically over 500 simulations to assess their
effects on alternans cycle length (CL). Of the 500 simulations, 83
were excluded from the analysis because alternans threshold CL
was below 100 ms or above 750 ms. Linear regression coefficients
for each of the parameters are plotted in order of decreasing
magnitude, with positive values plotted in red and negative values
plotted in blue. Asterisks indicate p,0.05 for the t-statistic. (B) Bar
graph of the predicted contribution of parameters to alternans
threshold CL in the cAF-remodeled cell. Ten of the twenty
parameters used in the regression analysis were altered from
control values to represent cAF remodeling (increases and
decreases indicated by upward and downward arrows, respective-
ly). Parameters whose changes were predicted to increase
(decrease) the alternans CL are plotted in red (blue). Some
unaltered parameters had nonzero predicted contributions to
alternans threshold CL due to nonzero sample means from the
regression analysis. The alternans threshold CL predicted by
regression analysis (245 ms) was very close to the actual alternans
threshold CL determined by simulation (244 ms).
(TIF)
S9 Figure Single-cell APD restitution in control model.
With default model parameter values, APD alternans occurred at
200 ms CL (black). When the RyR inactivation rate constant (kiCa)
was reduced to 95%, alternans occurred at slightly longer CLs
(red). These results were comparable to alternans onset data from
control patients [8].
(TIF)
S10 Figure APD and CaT oscillations in single-cell and
tissue models with Sato-Bers RyR formulation. Control
(black), cAF (red), and cAFalt (dotted red line) versions of the model
using the Sato-Bers RyR [27] were implemented in single cell (A
and B) and in tissue (C and D). In the cAFalt model, the
calsequestrin-bound RyR closing rate (k34) was decreased by 50%.
APD (A and C) and CaT (B and D) restitution data are plotted
showing the mean6SD range (control, gray shading, not visible;
cAF, pink shading; cAFalt, red hatching). Oscillations in APD and
CaT included but were not limited to alternans. Oscillations
exhibited the reverse of the rate dependence observed in models
using the original RyR formulation, with larger oscillations at
longer CL. APD oscillations in these models were diminished as
compared to the original models (see Fig. 1), and both APD and
CaT oscillations were attenuated in tissue.
(TIF)
S1 Text Supplemental methods.
(PDF)
S2 Text Supplemental equations.
(PDF)
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